Abbott Laboratories Financial Ratios — ABL.DE Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	16.11	17.9	7.37	6.59	11.99	3.63	1.11	4.97	7.54	8.86	13.12	11.96	9.35	19.88	8.83
Return on Assets (%)	7.82	9.35	4.68	5.43	10.73	2.98	0.74	3.3	5.46	6.4	9.57	9.27	7.75	17.33	7.76
Return on Capital (%)	10.85	- -	5.59	5.69	10.04	3.18	0.91	4.25	6.28	7.1	10.25	9.66	8.03	- -	7.78
Return on Invested Capital (%)	3.59	- -	5.24	5.81	7.84	6.23	0.49	5.43	8.17	9.4	13.51	12.77	10.21	- -	9.56
Gross Margin (%)	53.21	53.29	53.23	54.47	57.13	56.39	54.7	58.45	58.53	56.65	56.97	56.15	55.18	55.41	56.42
EBITDA Margin (%)	21.83	21.74	19.6	20.48	21.26	21	16.74	22.66	23.65	25.09	27.77	26.64	24.24	23.94	25.2
Operating Margin (%)	7.61	7.14	10.85	12.84	14.05	14.51	5.71	11.94	14.21	15.48	19.56	19.16	16.15	16.27	18.17
Incremental Operating Margin (%)	34.68	11.41	127.35	78.98	169.62	35.49	-22.36	65.43	66.52	30.51	36.23	-10.9	53.16	18.85	51.64
Pretax Margin (%)	5.77	-1.15	10.38	12.44	15.6	6.78	8.15	9.4	12.78	14.36	19.06	19.03	16.61	16.72	19.1
Profit Margin (%)	22.09	31.3	13.1	11.28	21.68	6.71	1.74	7.74	11.56	12.99	16.42	15.88	14.27	31.95	14.72
Net Income to Common Margin (%)	22.09	31.3	13.1	11.28	21.68	6.71	1.74	7.74	11.56	12.99	16.42	15.88	14.27	31.95	14.72
Effective Tax Rate (%)	8.9	- -	2.6	31.65	18.13	24.77	84.18	18.76	9.57	10	13.88	16.53	14.12	- -	22.94
Dvd Payout Ratio (%)	260.92	1,343.04	44.37	77.98	55.37	144.78	523.8	84.58	61.57	57.26	45.28	47.73	62.14	28.62	63.09
Sustainable Growth Rate (%)	-25.93	-222.49	4.1	1.45	5.35	-1.63	-4.71	0.77	2.9	3.79	7.18	6.25	3.54	14.19	3.26

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	15,415	20,476	6,561	7,830	9,001	22,006	27,924	19,566	18,894	19,649	19,006	17,716	15,628	15,021	13,860
ST Debt	3,375	2,391	3,173	4,437	3,130	1,325	714	207	1,478	220	754	2,251	1,080	1,500	3,033
LT Debt	12,040	18,085	3,388	3,393	5,871	20,681	27,210	19,359	17,416	19,429	18,252	15,465	14,548	13,521	10,827
Total Debt/EBITDA	3.3	4.94	1.7	1.89	2.07	5.03	6.09	2.82	2.5	2.26	1.59	1.52	1.61	1.5	1.24
Net Debt/EBITDA	1.84	2.34	0.8	0.91	0.92	0.77	4.04	2.27	1.89	1.37	0.69	0.59	0.8	0.65	0.39
Total Debt/EBIT	9.46	15.06	3.08	3.01	3.14	7.27	17.85	5.36	4.17	3.67	2.26	2.12	2.41	2.2	1.72
Net Debt/EBIT	5.28	7.11	1.45	1.45	1.4	1.12	11.84	4.31	3.15	2.22	0.98	0.82	1.2	0.95	0.55
EBITDA to Interest Expense	13.02	12.94	26.57	27.65	26.62	10.16	5.07	8.39	11.26	15.9	22.44	20.84	15.26	17.97	22.66
EBITDA-CapEx/Interest Expense	8.86	7.33	18.67	20.47	19.81	7.56	3.82	6.7	8.82	11.92	18.91	17.66	11.8	14.02	18.25
EBIT to Interest Expense	4.54	4.25	14.71	17.33	17.59	7.02	1.73	4.42	6.76	9.81	15.81	14.99	10.17	12.21	16.33
Interest Expense	359	320	145	150	163	431	904	826	670	546	533	558	637	559	493
Common Equity/Total Assets	50.97	53.4	79.22	85.56	93.32	73.28	61.88	71.56	73.21	71.36	74.47	80.56	85.26	88.95	86.85
Long-Term Debt/Equity (%)	49.09	67.45	13.41	15.68	27.53	99.83	87.5	63.01	55.64	58.87	50.67	41.9	37.47	28.23	20.52
Long-Term Debt/Capital (%)	26.05	32.02	8.33	7.85	12.33	34.03	36.13	28.54	25.31	27.12	24.26	19.85	18.59	15.42	12.06
Long-Term Debt/Total Assets (%)	19.97	26.9	7.89	8.23	14.23	39.27	35.69	28.82	25.65	26.78	24.27	20.78	19.87	16.61	12.49
Total Debt/Equity (%)	62.85	76.37	25.97	36.18	42.21	106.22	89.79	63.69	60.36	59.54	52.76	48	40.25	31.36	26.26
Total Debt/Capital (%)	33.35	36.26	16.13	18.12	18.91	36.21	37.08	28.84	27.46	27.43	25.27	22.74	19.97	17.13	15.43
Total Debt/Total Assets (%)	25.57	30.45	15.27	19	21.82	41.78	36.62	29.13	27.83	27.08	25.28	23.8	21.35	18.45	15.98
Net Debt to Equity	35.07	36.08	12.21	17.41	18.76	16.34	59.54	51.18	45.62	36.08	22.9	18.67	20.05	13.59	8.35
Net Debt/Capital (%)	21.82	21.18	8.29	9.63	9.39	8.03	28.1	24.57	21.99	18.38	12.61	10.13	10.9	8.13	5.42
EBITDA	4,673	4,142	3,852	4,147	4,339	4,379	4,585	6,928	7,546	8,684	11,963	11,629	9,721	10,043	11,169
EBITDA-CapEx	3,182	2,347	2,707	3,070	3,229	3,258	3,450	5,534	5,908	6,507	10,078	9,852	7,519	7,836	8,998
Operating Income (Loss)	1,629	1,360	2,133	2,599	2,867	3,026	1,564	3,650	4,532	5,357	8,425	8,362	6,478	6,825	8,053

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.52	1.14	0.85	0.43	0.67	2.82	1.08	0.45	0.38	0.6	0.78	0.66	0.53	0.56	0.54
Current Ratio	1.54	2.36	2.02	1.3	1.54	4.02	2.26	1.62	1.44	1.72	1.85	1.63	1.64	1.67	1.58
Quick Ratio	1.15	1.85	1.43	0.96	1.25	3.58	1.85	1.2	1.04	1.3	1.46	1.23	1.16	1.23	1.18
CFO/Avg Current Liab	0.55	0.65	0.29	0.37	0.3	0.4	0.72	0.7	0.62	0.69	0.84	0.67	0.5	0.61	0.62
Common Equity/Total Assets	50.97	53.4	79.22	85.56	93.32	73.28	61.88	71.56	73.21	71.36	74.47	80.56	85.26	88.95	86.85
Long-Term Debt/Equity (%)	49.09	67.45	13.41	15.68	27.53	99.83	87.5	63.01	55.64	58.87	50.67	41.9	37.47	28.23	20.52
Long-Term Debt/Capital (%)	26.05	32.02	8.33	7.85	12.33	34.03	36.13	28.54	25.31	27.12	24.26	19.85	18.59	15.42	12.06
Long-Term Debt/Total Assets (%)	19.97	26.9	7.89	8.23	14.23	39.27	35.69	28.82	25.65	26.78	24.27	20.78	19.87	16.61	12.49
Total Debt/Equity (%)	62.85	76.37	25.97	36.18	42.21	106.22	89.79	63.69	60.36	59.54	52.76	48	40.25	31.36	26.26
Total Debt/Capital (%)	33.35	36.26	16.13	18.12	18.91	36.21	37.08	28.84	27.46	27.43	25.27	22.74	19.97	17.13	15.43
Total Debt/Total Assets (%)	25.57	30.45	15.27	19	21.82	41.78	36.62	29.13	27.83	27.08	25.28	23.8	21.35	18.45	15.98
CFO/Total Liabilities	25.09	23.04	18.79	18.78	14.89	10.03	12.34	17.28	16.77	19.98	26.89	25.53	21.12	25.54	28.18
CFO/CapEx	6.02	5.19	2.9	3.41	2.67	2.86	4.91	4.52	3.75	3.63	5.59	5.39	3.3	3.88	4.41
Altman's Z-Score	3.16	2.98	5.18	4.72	4.8	3.3	3.92	5.39	5.74	5.91	7.1	6.28	6.38	6.28	6.48

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	2.88	2.49	3.39	5.35	5.83	6.26	6.45	5.86	6.02	5.85	6.68	6.87	6.28	6.22	5.97
Days Sales Outstanding	126.75	146.55	107.69	68.25	62.64	58.34	56.62	62.26	60.68	62.43	54.66	53.12	58.16	58.69	61.15
Inventory Turnover	3.1	2.51	2.83	3.46	3.34	3.61	4.11	3.44	3.26	3.22	3.65	3.38	2.82	2.93	3.05
Days Inventory Outstanding	117.93	145.14	128.76	105.64	109.37	101	88.76	106.25	111.89	113.47	100.12	108.02	129.38	124.53	119.8
Accounts Payable Turnover	6.21	5.35	5.73	8.77	8.11	7.91	7.58	4.8	4.42	4.36	4.47	4.47	4.13	4.32	4.65
Accounts Payable Turnover Days	58.78	68.25	63.66	41.6	44.98	46.17	48.13	76.06	82.64	83.68	81.61	81.62	88.43	84.53	78.49
Cash Conversion Cycle	185.91	223.44	172.79	132.29	127.03	113.17	97.25	92.44	89.92	92.22	73.17	79.52	99.11	98.69	102.47
Inventory to Cash Days	8.82	1.41	-21.07	-37.39	-46.73	-42.66	-32.14	-43.99	-51.22	-51.04	-45.46	-54.9	-71.22	-65.84	-58.65
Inventories	3,284	3,793	2,693	2,643	2,599	2,434	3,601	3,796	4,316	5,012	5,157	6,173	6,570	6,194	6,488
Raw Materials	631	818	478	558	539	516	790	890	972	1,270	1,382	1,688	1,817	1,654	1,608
Work In Process	432	629	349	278	316	294	472	499	560	712	694	680	807	840	904
Finished Goods	2,221	2,346	1,866	1,807	1,744	1,624	2,339	2,407	2,784	3,030	3,081	3,805	3,946	3,700	3,976
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	74,810	76,608	78,525	69,528	67,773	56,247	100,116	123,962	154,544	193,128	249,786	192,069	189,944	197,145	216,093
- Cash & Cash Equivalents	6,813	10,802	3,475	4,063	5,001	18,620	9,407	3,844	3,860	6,838	9,799	9,882	6,896	7,616	8,522
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	86	92	96	113	115	179	201	198	213	219	222	219	224	237	641
+ Total Debt	15,415	20,476	6,561	7,830	9,001	22,006	27,924	19,566	18,894	19,649	19,006	17,716	15,628	15,021	13,860
Enterprise Value	82,213	82,002	77,084	73,011	70,764	59,657	118,631	139,640	169,511	205,848	258,765	199,834	198,517	204,436	221,655
Total Capital	46,225	56,474	40,684	43,200	47,607	60,777	75,309	67,836	68,807	71,640	75,226	77,901	78,275	87,672	89,809
Total Debt/Capital (%)	33.35	36.26	16.13	18.12	18.91	36.21	37.08	28.84	27.46	27.43	25.27	22.74	19.97	17.13	15.43
Total Debt / EV	0.19	0.25	0.09	0.11	0.13	0.37	0.24	0.14	0.11	0.1	0.07	0.09	0.08	0.07	0.06
EV/Sales	3.84	4.3	3.92	3.61	3.47	2.86	4.33	4.57	5.31	5.95	6.01	4.58	4.95	4.87	5
EV/EBITDA	17.59	19.8	20.01	17.61	16.31	13.62	25.87	20.16	22.46	23.7	21.63	17.18	20.42	20.36	19.85
EV/EBIT	50.47	60.3	36.14	28.09	24.68	19.71	75.85	38.26	37.4	38.43	30.71	23.9	30.64	29.95	27.52
EV/Cash Flow to Firm	8.84	9.14	22.24	19.33	22.83	16.91	20.76	20.03	25.14	24.53	23.54	19.89	25.42	21.24	22.29
EV/Free Cash Flow to Firm	7.62	7.62	16.72	15.04	16.81	12.83	17.32	16.69	20.23	19.48	20.1	16.9	19.83	17.28	18.29
Diluted Market Cap	74,810	77,353	79,838	70,402	69,307	56,634	100,426	124,978	156,166	194,739	253,314	194,966	191,579	199,001	217,636
Diluted Enterprise Value	83,498	87,119	83,020	74,282	73,422	60,199	119,144	140,898	171,413	207,769	262,743	203,019	200,535	206,643	223,615
EV per Share	52.35	52.01	49.79	48.41	48.05	40.5	68.04	79.54	96.18	116.22	146.69	114.99	114.48	118.06	127.64
TTM Sales	21,407	19,050	19,657	20,247	20,405	20,853	27,390	30,578	31,904	34,608	43,075	43,653	40,109	41,950	44,328
TTM EBITDA	4,673	4,142	3,852	4,147	4,339	4,379	4,585	6,928	7,546	8,684	11,963	11,629	9,721	10,043	11,169
TTM Operating Income	1,629	1,360	2,133	2,599	2,867	3,026	1,564	3,650	4,532	5,357	8,425	8,362	6,478	6,825	8,053
TTM Cash Flow to Firm	9,297	8,969	3,465	3,778	3,099	3,527	5,713	6,971	6,742	8,392	10,992	10,047	7,808	9,626	9,946
TTM Free Cash Flow to Firm	10,788	10,764	4,610	4,855	4,209	4,648	6,848	8,365	8,380	10,569	12,877	11,824	10,010	11,833	12,117

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	7.15	6.96	17.86	14.82	17	13.1	14.98	16.24	20.09	19.32	20.4	17.17	20.25	18.49	18.54
EV/EBIT	50.47	60.3	36.14	28.09	24.68	19.71	75.85	38.26	37.4	38.43	30.71	23.9	30.64	29.95	27.52
Enterprise Value	82,213	82,002	77,084	73,011	70,764	59,657	118,631	139,640	169,511	205,848	258,765	199,834	198,517	204,436	221,655
Low Price	21.67	44.33	32.46	36.22	38.56	36.52	38.5	56.25	66.41	63.03	105.24	94.57	89.9	97.39	110.79
EV/Sales	3.84	4.3	3.92	3.61	3.47	2.86	4.33	4.57	5.31	5.95	6.01	4.58	4.95	4.87	5
EV/EBITDA	17.59	19.8	20.01	17.61	16.31	13.62	25.87	20.16	22.46	23.7	21.63	17.18	20.42	20.36	19.85
Price/Earnings	15.82	12.85	30.48	30.44	15.32	40.18	209.89	52.35	41.92	42.97	35.33	27.7	33.19	14.71	33.12
Price/Earnings Average	15.5	12.49	25.99	29.99	14.93	42.64	176.91	47.59	38.45	37.86	30.31	28.03	31.61	14.39	34.42
Price/Earnings High	18.13	13.08	30.49	33.82	17.23	48.05	212.33	57.05	42.53	46.06	35.75	35.39	34.89	15.82	37.94
Price/Earnings Low	7.2	11.72	19.51	23.91	12.84	38.42	140.72	41.7	31.75	24.84	26.26	23.7	27.24	12.58	29.49
Price/Book Value	2.43	2.13	2.31	1.97	1.76	1.46	2.12	2.58	3.11	3.73	4.46	3.2	3.04	2.72	2.87
Price/Book Value Average	2.39	2.07	1.97	1.94	1.72	1.55	1.79	2.34	2.85	3.29	3.83	3.24	2.9	2.66	2.98
Price/Book Value High	2.79	2.17	2.31	2.19	1.98	1.74	2.15	2.81	3.16	4	4.51	4.09	3.2	2.93	3.29
Price/Book Value Low	1.11	1.95	1.48	1.55	1.48	1.39	1.42	2.05	2.36	2.16	3.32	2.74	2.5	2.33	2.55
Price/Tangible Book Value	-64	31.26	8.05	12.94	11.06	6.62	-6.95	-10.8	-17.33	-34.96	4,625.66	52.59	29.99	10.86	9.31
Price/Tangible Book Value Average	-62.71	30.38	6.86	12.75	10.78	7.03	-5.86	-9.82	-15.89	-30.8	3,969.33	53.21	28.57	10.63	9.68
Price/Tangible Book Value High	-73.35	31.82	8.05	14.37	12.44	7.92	-7.04	-11.77	-17.58	-37.48	4,681.15	67.18	31.53	11.69	10.66
Price/Tangible Book Value Low	-29.11	28.52	5.15	10.16	9.27	6.33	-4.66	-8.61	-13.12	-20.21	3,438.05	45	24.61	9.29	8.29
Price/Sales	3.49	4.02	3.99	3.43	3.32	2.7	3.66	4.05	4.84	5.58	5.8	4.4	4.74	4.7	4.87
Price/Sales Average	3.42	3.91	3.41	3.38	3.24	2.86	3.08	3.69	4.44	4.92	4.98	4.45	4.51	4.6	5.07
Price/Sales High	4	4.09	4	3.81	3.73	3.23	3.7	4.42	4.92	5.98	5.87	5.62	4.98	5.05	5.58
Price/Sales Low	1.59	3.67	2.56	2.7	2.78	2.58	2.45	3.23	3.67	3.23	4.31	3.76	3.89	4.02	4.34
Price/Cash Flow	8.34	8.22	23.62	18.92	22.85	17.56	17.97	19.68	25.19	24.44	23.71	20.05	26.16	23.04	22.59
Price/Cash Flow Average	8.17	8	20.14	18.64	22.26	18.64	15.15	17.89	23.1	21.54	20.35	20.28	24.92	22.53	23.48
Price/Cash Flow High	9.56	8.37	23.63	21.02	25.69	21	18.18	21.44	25.56	26.21	24	25.61	27.5	24.78	25.87
Price/Cash Flow Low	3.79	7.5	15.12	14.86	19.14	16.79	12.05	15.67	19.08	14.13	17.63	17.15	21.47	19.71	20.11
Price/Free Cash Flow Average	7.01	6.77	15.23	14.59	16.56	13.9	12.62	14.77	18.43	17.03	17.5	17.37	19.28	18.08	19.27
Price/Free Cash Flow High	8.2	7.09	17.87	16.46	19.12	15.66	15.15	17.7	20.38	20.72	20.64	21.93	21.28	19.88	21.24
Price/Free Cash Flow Low	3.25	6.35	11.43	11.64	14.25	12.52	10.04	12.94	15.21	11.17	15.16	14.69	16.61	15.81	16.51
EV/Sales Average	3.83	4.42	3.57	3.57	3.44	3.03	3.76	4.21	4.92	5.29	5.19	4.64	4.73	4.78	5.2
EV/Sales High	4.41	4.61	4.16	4.01	3.94	3.4	4.38	4.94	5.39	6.36	6.09	5.8	5.2	5.24	5.72
EV/Sales Low	2	4.18	2.72	2.89	2.98	2.75	3.13	3.75	4.15	3.6	4.53	3.95	4.11	4.2	4.48
EV/EBITDA Average	17.54	20.34	18.21	17.45	16.16	14.45	22.49	18.56	20.81	21.1	18.71	17.4	19.53	19.96	20.64
EV/EBITDA High	20.21	21.19	21.21	19.56	18.51	16.18	26.17	21.8	22.8	25.34	21.92	21.79	21.46	21.87	22.7
EV/EBITDA Low	9.14	19.23	13.87	14.11	14.03	13.1	18.72	16.55	17.53	14.36	16.31	14.82	16.96	17.55	17.76
EV/EBIT Average	50.33	61.94	32.88	27.85	24.46	20.91	65.92	35.23	34.64	34.2	26.56	24.2	29.31	29.37	28.63
EV/EBIT High	57.96	64.53	38.31	31.21	28.01	23.41	76.73	41.38	37.97	41.08	31.12	30.3	32.21	32.19	31.48
EV/EBIT Low	26.22	58.58	25.05	22.51	21.24	18.95	54.89	31.42	29.19	23.27	23.16	20.62	25.45	25.83	24.63
Last Price	47.64	48.59	50.72	46.11	46.02	38.19	57.42	70.61	87.68	109.04	141.6	110.52	109.54	113.84	124.43
High Price	54.59	49.47	50.73	51.22	51.74	45.67	58.09	76.95	88.97	116.9	143.29	141.18	115.15	122.45	142.52
Enterprise Value Average	81,986	84,239	70,140	72,372	70,139	63,266	103,105	128,604	156,998	183,201	223,773	202,387	189,869	200,460	230,545
Enterprise Value High	94,422	87,758	81,719	81,121	80,316	70,837	119,999	151,023	172,062	220,082	262,211	253,388	208,638	219,687	253,481
Enterprise Value Low	42,718	79,665	53,437	58,496	60,897	57,348	85,842	114,672	132,294	124,669	195,084	172,395	164,841	176,284	198,372

Shares Outstanding	1,570	1,577	1,548	1,508	1,473	1,473	1,744	1,756	1,763	1,771	1,764	1,738	1,734	1,732	1,737
Diluted Weighted Avg Shares	1,570	1,592	1,574	1,527	1,506	1,483	1,749	1,770	1,781	1,786	1,789	1,764	1,749	1,748	1,749
Basic Weighted Avg Shares	1,570	1,577	1,548	1,508	1,473	1,473	1,744	1,756	1,763	1,771	1,764	1,738	1,734	1,732	1,737
Revenue per Share	13.63	12.08	12.7	13.43	13.86	14.16	15.71	17.42	18.1	19.54	24.42	25.12	23.13	24.22	25.53
EBITDA per Share	2.98	2.63	2.49	2.75	2.95	2.97	2.63	3.95	4.28	4.9	6.78	6.69	5.61	5.8	6.43
Operating Income per Share	1.04	0.86	1.38	1.72	1.95	2.05	0.9	2.08	2.57	3.02	4.78	4.81	3.74	3.94	4.64
Basic EPS, GAAP	3.01	3.78	1.66	1.51	3	0.95	0.27	1.35	2.09	2.54	4.01	3.99	3.3	7.74	3.76
Basic EPS from Cont Ops	0.72	0.15	1.28	1.14	1.77	0.72	0.2	1.33	2.09	2.52	4.01	3.99	3.3	7.74	3.76
Diluted EPS, GAAP	3.01	3.75	1.64	1.5	2.94	0.94	0.27	1.34	2.07	2.52	3.95	3.93	3.27	7.67	3.73
Diluted EPS from Cont Ops	0.72	0.15	1.26	1.13	1.73	0.72	0.2	1.32	2.07	2.5	3.95	3.93	3.27	7.67	3.73
Dividend per Share	1.87	2.02	0.57	0.89	0.98	1.04	1.06	1.12	1.29	1.45	1.82	1.9	2.05	2.22	2.37
Cash Flow per Share	5.71	5.91	2.15	2.44	2.01	2.17	3.19	3.59	3.48	4.46	5.97	5.51	4.19	4.94	5.51
Free Cash Flow per Basic Share	4.76	4.77	1.41	1.72	1.26	1.41	2.54	2.79	2.55	3.23	4.9	4.49	2.92	3.67	4.26
Cash & Equivalents per Share	5.16	9.62	5.23	2.96	4.16	12.75	5.51	2.33	2.35	4.04	5.81	5.85	4.2	4.6	5.15
Book Value per Share	19.57	22.77	21.98	23.38	26.14	26.2	27.06	27.38	28.2	29.23	31.74	34.51	36	41.82	43.37
Tangible Book Value per Share	-0.74	1.55	6.3	3.56	4.16	5.77	-8.26	-6.54	-5.06	-3.12	0.03	2.1	3.65	10.48	13.37

Abbott Laboratories

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)